of symptoms relief and the improvement of HAE and the median time to end of the attacks. Safety was assessed in terms of adverse events. All participants gave written informed consent. Results: There were 21 acute attacks, 14 for icatibant and 7 for FFP. The median time to onset of symptoms relief was 27 and 45 minutes for icatibant and FFP respectively (P ¼ 0.106). The median time to complete resolution of all simptoms was 240 and 2880 minutes respectively for icatibant and FFP (P ¼ 0.002). All patients with Icatibant experienced generally mild transient injection-site reactions (erythema and swelling, and pain) wich resolved spontaneously without intervention. No drug-related serious adverse events were observed with icatibant and administration of FFP was not associated with infections of human inmunodeficiency virus, or hepatitis virus. Conclusions: Icatibant was effective and generally well tolerated, providing rapid regression of symptoms associated with acute HAE attacks at all anatomic sites. Results: Eighty-nine of these 97 patients could identify possible factors, potentially related to the onset of attacks. Events associated with an increased propensity for having an attack were physical exertion in 64, mental stress in 53, and mechanical trauma in 53 of these patients. The average number of triggering factors recognized by patients was 2.7 in males and 4 in females.
Characterization of the Factors Triggering an Edematous Attack in Hereditary Angioedema
Zsuzsanna Zotter, Dorottya Csuka, PhD, Erika Szabó, MD, George FustDSc, MD, PhD, Lilian Varga, PhD, and Henriette FarkasDSc, MD, PhD. 3rd Department of Internal Medicine, Semmelweis University, Budapest, Hungary. Background: Hereditary angioedema due to C1-inhibitor deficiency (HAE-C1-INH) is characterized by recurrent attacks of subcutaneous and/or submucosal edema. The mechanisms involved in the development of edematous attacks are being researched extensively and thus, abundant information is available. By contrast, only a few surveys have been conducted on the triggering factors of attacks. Methods: Data recorded between 2004 and 2010 by 97 HAE patients in their diaries have been analyzed. Results: Eighty-nine of these 97 patients could identify possible factors, potentially related to the onset of attacks. Events associated with an increased propensity for having an attack were physical exertion in 64, mental stress in 53, and mechanical trauma in 53 of these patients. The average number of triggering factors recognized by patients was 2.7 in males and 4 in females. Based on the records of patient diaries, 3176 attacks were diagnosed and patients could identify the triggering factor in 30 per cent of these. The leading provoking factor was mental stress (21%). Analyzing interim distribution during a year showed a higher-than-average number of attacks in March, May, October, and December in almost all the 7 years studied. Clustering of the attacks in March was particularly typical of males and of attacks with an unknown provoking factor. Attacks triggered by stress clustered in the spring and in the autumn. Examining the trigger factors based on the location revealed different patterns among the trigger factors. Conclusions: According to our results, 92% of patients can identify a factor that triggers an attack -this proportion is higher than that published in the literature. It is important to explore triggering factors, because avoiding these may reduce the number of apparent attacks. Physical exertion was the most common provoking factor. A possible triggering factor could be identified in almost one-third of the attacks. The seasonal clustering of stress-induced attacks shows similarity with the acute exacerbations of psychosomatic disorders. This suggests that psychological support may positively influence the course of the disease.
Hereditary Angioedema: Report of Ten Mexican Patients at West National Medical Center in Guadalajara City
Ileana Madrigal, MD. UMAE-HECMNO-IMSS, Guadalajara, Jalisco, Mexico. Background: Hereditary angioedema (HAE) is an autosomal dominant inherited condition characterized by swelling of the skin, subcutaneous tissue, and the walls of almost all organs, including upper respiratory and gastrointestinal systems. The aim of this paper is to show the medical community clinical characteristics of 10 Mexican patients with HAE. Methods: We reviewed medical records of 10 patients with hereditary angioedema. Results: All are women, mean age 36 years; 4 of them with C4 0 mg/dL and the rest with serum levels less than 7 mg/dL. In all patients, C1 INH was determined quantitatively with low serum levels. It was also carried out qualitative determination of C1 INH with negative results in all patients. In 1 patient it was diagnosed also systemic lupus erythematosus. Conclusions: All patients presented here have HAE type I and the diagnosis was made according to the criteria defined by Cicardi Zingale. They have been long-term treated with danazol with different response, dose range of 100 to 400 mg daily, depending of clinical response in each patient. In only 2 of them was used a selective bradykinin B2 receptor antagonist icatibant with good response. female and 23 male, with ages between 9 and 67 years. They belonged to 33 families and usually had begun to present clinical symptoms within the second decade of life. Diagnosis had been made from 06 months to 59 years after first symptoms. Spontaneous swelling was frequent, but attacks were also precipitated by trauma, pressure and emotional stress. Skin swellings were presented in 77 patients and abdominal pain attacks were related by 56 patients. Respiratory symptoms were experienced by 45 patients, 31 of them presented laringeal edema. Low levels of C4 had been noticed in all patients. Ninety percent of the patients presented quantitative deficiency. Prophylactic treatment with attenuated androgens was administered in low doses to 50 patients and was totally effective in 45, without significant side effects. Sixteen patients presented few or none manifestations without prophylactic medications. Conclusions: The described patients are similar to those reported in literature and the prophylactic treatment with attenuated androgens has been effective in controlling manifestations. The diagnosis is still late for some patients.
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